Options to Reform the European Union Legislation on GMOs: Risk Governance.


Journal

Trends in biotechnology
ISSN: 1879-3096
Titre abrégé: Trends Biotechnol
Pays: England
ID NLM: 8310903

Informations de publication

Date de publication:
04 2020
Historique:
received: 03 12 2019
accepted: 06 12 2019
entrez: 16 3 2020
pubmed: 17 3 2020
medline: 16 7 2021
Statut: ppublish

Résumé

Here, we discuss options to reform the EU genetically modified organism (GMO) regulatory framework, to make risk assessment and decision-making more consistent with scientific principles, and to lay the groundwork for international coherence. We discussed the scope and definitions in a previous article and, thus, here we focus on the procedures for risk assessment and risk management.

Identifiants

pubmed: 32171418
pii: S0167-7799(19)30311-7
doi: 10.1016/j.tibtech.2019.12.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

349-351

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Dennis Eriksson (D)

Department of Plant Breeding, Swedish University of Agricultural Sciences, 23053 Alnarp, Sweden. Electronic address: dennis.eriksson@slu.se.

René Custers (R)

VIB, Rijvisschestraat 120, Ghent BE-9052, Belgium.

Karin Edvardsson Björnberg (K)

Division of Philosophy, KTH Royal Institute of Technology, Teknikringen 76, 100 44 Stockholm, Sweden.

Sven Ove Hansson (SO)

Division of Philosophy, KTH Royal Institute of Technology, Teknikringen 76, 100 44 Stockholm, Sweden; Department of Crop Production Ecology, Swedish University of Agricultural Sciences, Uppsala, Sweden.

Kai Purnhagen (K)

Law Group, Department of Social Sciences, Wageningen University, Hollandseweg 1, 6706, KN, Wageningen, The Netherlands; Rotterdam Institute of Law and Economics, Law School, Erasmus University of Rotterdam, Burg. Oudlaan, 50 3062, PA, Rotterdam, The Netherlands.

Matin Qaim (M)

Department of Agricultural Economics and Rural Development, University of Goettingen, 37073 Goettingen, Germany.

Jörg Romeis (J)

Research Division Agroecology and Environment, Agroscope, Reckenholzstrasse 191, 8046 Zurich, Switzerland.

Joachim Schiemann (J)

Institute for Biosafety in Plant Biotechnology, Julius Kühn-Institut (JKI), 06484 Quedlinburg, Germany.

Stephan Schleissing (S)

Institute of Technology - Theology - Natural Sciences at the Ludwig-Maximilians-Universität München, 80539 München, Germany.

Jale Tosun (J)

Institute of Political Science, Heidelberg University, Bergheimer Strasse 58, 69115 Heidelberg, Germany; Heidelberg Center for the Environment, Heidelberg University, Im Neuenheimer Feld 229, 69120 Heidelberg, Germany.

Richard G F Visser (RGF)

Plant Breeding, Wageningen University & Research, PO Box 386, 6700AJ Wageningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH